Greenspan, Bernanke and Yellen urge Supreme Court to let Lisa Cook keep her job as a Fed governor [deltaMinutes] mins ago Now
Day: September 25, 2025
Vatican prosecutors suffer embarrassing loss as tribunal says their appeal is inadmissible
Phil Mickelson is an unwanted outsider in what could have been his Ryder Cup at Bethpage
Viktor Hovland’s great pursuits: A perfect golf swing and the truth about UFOs [deltaMinutes] mins ago Now
Cycling team urged to remove ‘Israel’ from its name due to pro-Palestinian protests [deltaMinutes] mins ago Now
The Minister of Finance, has said nobody is more aware than himself of the dangers of repeating the mistakes of the financial crash.
Shooting at school in northeast Brazil leaves 2 teenagers dead, 3 others injured
UN court hears case of alleged Rwandan genocide financier stranded in legal limbo [deltaMinutes] mins ago Now
Stephanie Lewis told Newsweek: “She has a smile that lights up any room and a heart overflowing with love.”
September 25, 2025 Hour: 11:36 am
Volunteer patients will undergo personalized treatments based on their genetic profiles.
On September 25, 2025, the Russian government initiated the preparatory phase for clinical trials of a personalized vaccine aimed at combating melanoma, a particularly aggressive form of skin cancer, reports 24brussels.
Russian scientists plan to select volunteers within 45 days who will participate in immunization sessions, marking a pivotal development in next-generation oncology therapies. Previously, the Health Ministry authorized the production of the initial doses of the melanoma vaccine.
Alexander Gintsburg, director of the Gamaleya National Research Center, confirmed that medical teams have already identified groups of volunteer patients who will receive individualized treatments based on their genetic profiles. Each volunteer’s genomic analysis will determine potential adverse effects and specific benefits tailored to their biology.
“In science, every mistake shows us the path we should not take, and every finding brings us closer to the solution,” Gintsburg stated, emphasizing the critical need for precision in this research.
The vaccine utilizes a messenger RNA (mRNA) platform, representing a notable advancement in personalized oncology immunotherapy. By analyzing the molecular structure of each tumor, a unique formula is crafted to equip the immune system to recognize and target cancer cells while preserving healthy tissue.
This initiative positions Russia as a frontrunner in cancer vaccine research and development, focusing on innovative therapies to combat melanoma and other highly fatal diseases. The Russian health project has generated considerable international interest.
Nicaraguan Co-President Rosario Murillo announced her country’s involvement in the clinical trials and confirmed that Nicaraguan authorities are working on establishing a nuclear medicine center in Managua in collaboration with Russia’s State Atomic Energy Corporation.
As the situation develops, attention will also remain on the European Commission’s recent proposals for a 19th package of sanctions against Russia, targeting the country’s energy and financial sectors amid ongoing tensions in the Russia–Ukraine conflict.